What do consumers want to know about drugs (medication and lifestyle) in their pregnancy journey?

Eva L. Pijpers, Treasure M McGuire, Sanne Kreijkamp-Kaspers, Laura Deckx, Wendy Brodribb, Marie Van Driel

Research output: Contribution to journalMeeting AbstractResearchpeer-review

19 Downloads (Pure)

Abstract

Introduction
Drug use during pregnancy is common; yet data to support safety are mainly case reports and retrospective studies. There is also growing evidence for harmful fetal effects when treatment of certain maternal conditions is inadequate. Seeking information is a coping strategy and can assist with decision-making.

Aim
This study aimed to identify the medicines information needs of women across pregnancy stages and explore whether their questions could be justified by actual pregnancy risk.

Methods
We conducted a retrospective, mixed method study of pregnancy-related calls to an Australian consumer medicines call centre, NPS Medicines Line (September 2002-June 2010). Call characteristics were compared for pregnancy (n = 4,573) and non-pregnancy (n = 118,547) questions. Drugs of interest, motivations to call and question themes were analysed across pregnancy stages, with medicines assessed for risk, using the Australian categorisation system for prescribing medicines in pregnancy. Call narratives were explored for stage-specific themes.

Results
Pregnancy-related enquiries were prompted more often by conflicting or inadequate information and request for second opinion. Most questions concerned safety. Psychotropic medication and fertility were strong drivers to seek information in preconception. Everyday illnesses and self-medication with Over-The-Counter products were of increasing concern as pregnancy progressed, with medicines classified as ‘safe’ accounting for 34% of questions.

Discussion
Analysis of real world, pregnancy-related questions demonstrates that women are concerned about safe drug use in pregnancy and are likely to overestimate risk. Health care professionals should proactively address drug information gaps of women’s pregnancy stage-specific information needs during routine consultations.
Original languageEnglish
Pages (from-to)e20
JournalResearch in Social and Administrative Pharmacy
Volume12
Issue number5
DOIs
Publication statusPublished - Sep 2016
EventAPSA-ASCEPT Joint Scientific Meeting 2015: Drugs to medicines: up close and personal - Hotel Grand Chancellor, Hobart, Australia
Duration: 29 Nov 20152 Dec 2015
http://www.asceptasm.com/2015-annual-scientific-meeting/program-2015/

Fingerprint Dive into the research topics of 'What do consumers want to know about drugs (medication and lifestyle) in their pregnancy journey?'. Together they form a unique fingerprint.

Cite this